Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about REACTIVE ASTROCYTES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | REACTIVE ASTROCYTES |
Knowledge base pages for this entity
graph TD
REACTIVE_ASTROCYTES["REACTIVE ASTROCYTES"]
REACTIVE_ASTROCYTES -->|"contributes to"| Neuroinflammation["Neuroinflammation"]
REACTIVE_ASTROCYTES -->|"contributes to"| Neurodegeneration["Neurodegeneration"]
REACTIVE_ASTROCYTES -->|"upregulates"| C3["C3"]
REACTIVE_ASTROCYTES -->|"upregulates"| CXCL10["CXCL10"]
REACTIVE_ASTROCYTES -->|"mediates"| Neurotoxicity["Neurotoxicity"]
REACTIVE_ASTROCYTES -->|"involved_in"| Central_Nervous_System_Degener["Central Nervous System Degeneration"]
REACTIVE_ASTROCYTES -->|"involved_in"| Central_Nervous_System_Repair["Central Nervous System Repair"]
REACTIVE_ASTROCYTES -->|"upregulates"| Neuronal_Fatty_Acid_Oxidation["Neuronal Fatty Acid Oxidation"]
TNF__["TNF-Alpha"] -->|"activates"| REACTIVE_ASTROCYTES
IL_1_["IL-1Alpha"] -->|"activates"| REACTIVE_ASTROCYTES
C1Q["C1Q"] -->|"activates"| REACTIVE_ASTROCYTES
GFAP["GFAP"] -.biomarker for.-> REACTIVE_ASTROCYTES
TNF["TNF"] -->|"activates"| REACTIVE_ASTROCYTES
Neuroinflammation -->|"activates"| REACTIVE_ASTROCYTES
Lxr_Agonist["Lxr Agonist"] -->|"suppresses"| REACTIVE_ASTROCYTES
amyloid_beta["amyloid beta"] -->|"causes"| REACTIVE_ASTROCYTES| Target | Relation | Type | Str |
|---|---|---|---|
| Central Nervous System Degeneration | involved_in | process | 0.90 |
| Central Nervous System Repair | involved_in | process | 0.90 |
| Neuroinflammation | contributes_to | process | 0.90 |
| Neurodegeneration | contributes_to | process | 0.90 |
| Neurotoxicity | mediates | process | 0.90 |
| CXCL10 | upregulates | protein | 0.90 |
| C3 | upregulates | protein | 0.90 |
| Neuronal Fatty Acid Oxidation | upregulates | process | 0.85 |
| Alzheimer'S Disease | biomarker_for | disease | 0.85 |
| Oxidative Stress | causes | process | 0.85 |
| Fatty Acid Biosynthesis | inhibits | process | 0.80 |
| Phospholipid Biosynthesis | inhibits | process | 0.80 |
| Microglia Activation | activates | process | 0.75 |
| Microglia Activation | inhibits | process | 0.75 |
| oxidative stress | activates | process | 0.70 |
| Huntington's disease | associated_with | disease | 0.70 |
| innate immune system | regulates | process | 0.70 |
| acquired immune system | regulates | process | 0.70 |
| neuroinflammation | activates | process | 0.70 |
| neuronal loss | activates | process | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GFAP | biomarker_for | protein | 0.95 |
| C1Q | activates | protein | 0.95 |
| TNF-Α | activates | protein | 0.95 |
| IL-1Α | activates | protein | 0.95 |
| TNF | activates | entity | 0.92 |
| 39402379 | present in | paper | 0.90 |
| Lxr Activation | downregulates | mechanism | 0.85 |
| neuroinflammation | activates | process | 0.85 |
| Lxr Agonist | suppresses | drug | 0.85 |
| Neuroinflammation | activates | process | 0.85 |
| amyloid beta | causes | protein | 0.80 |
| LXR agonist | downregulates | drug | 0.75 |
| STAT3 | activates | protein | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Circadian Rhythm Entrainment of Reactive Astrocytes | 0.722 | neurodegeneration | Astrocyte reactivity subtypes in neurode |
| GFAP-Bearing Circulating Extracellular Vesicles Originating | 0.640 | - | What blood-brain barrier permeability ch |
| AQP4 Missorting in Reactive Astrocytes Drives Glymphatic Fai | 0.580 | neurodegeneration | What are the specific molecular mechanis |
| Reactive astrocytes and cholinesterase-rich low-acetylcholin | 0.440 | neurodegeneration | What determines the temporal sequence of |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Circadian gene expression effects of SD vs ketamine | exploratory | depression | 0.950 | 0.00 | C57BL/6J mice | proposed | N/A |
| CLOCK/BMAL1 regulation of ICC autophagy in GERD model | exploratory | gastroesophageal reflux diseas | 0.900 | 0.00 | primary esophageal interstitia | proposed | N/A |
| Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Brainstem Circuit Modulation for PSP | clinical | ALS | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Non-Dopaminergic Neurotransmitter Degeneration in PD - Experiment Desi | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury. [PMID:40269168] | Ruan W, Li T, Bang IH, Lee J, Deng W, Ma | Nature | 2025 | 1 |
| Obstructive sleep apnea syndrome, orexin, and sleep-wake cycle: The link with th [PMID:39864923] | Fernandes M, Liguori C | Handb Clin Neurol | 2025 | 1 |
| Circadian Influences on Brain Lipid Metabolism and Neurodegenerative Diseases. [PMID:39728504] | Hussain Y, Dar MI, Pan X | Metabolites | 2024 | 1 |
| Circadian rhythm regulates the function of immune cells and participates in the [PMID:38678017] | Zeng Y, Guo Z, Wu M, Chen F, Chen L | Cell Death Discov | 2024 | 1 |
| Circadian Clock Regulation on Lipid Metabolism and Metabolic Diseases. [PMID:32705594] | Pan X, Mota S, Zhang B | Adv Exp Med Biol | 2020 | 1 |
| BMAL1 attenuates myocardial infarction-induced fibrosis via suppressing p-SMAD3/ [PMID:41909150] | Zhang D, Wang H, Gu Z, Zhang L, Hu Z, Wa | Biochemistry and biophysics re | 2026 | 0 |
| Multifunctional hydrogel delivery of mesenchymal stem cell secretome suppresses [PMID:41092646] | Lin L, Liang X, Xu Z, Li Y, Guo Z et al. | Biomaterials | 2026 | 0 |
| The Liver Clock Tunes Transcriptional Rhythms in Skeletal Muscle to Regulate Mit [PMID:41486525] | Sica V, Sato T, Tsialtas I, Hernandez S, | J Biol Rhythms | 2026 | 0 |
| Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-pr [PMID:41578008] | Tsameret S, Froy O, Matz Y, Landau Z, Tw | Diabetologia | 2026 | 0 |
| Bmal1 Regulates Vascular Calcification via Noncanonical Circadian Pathway-Brief [PMID:41608773] | He M, Sun Y, Tang C, Huang F, Zhu Z et a | Arterioscler Thromb Vasc Biol | 2026 | 0 |
| Liver-specific knockout of CD73 exacerbated alcohol-associated steatohepatitis b [PMID:41833677] | Wu X, Zhang Q, Wang QQ, Liu ZN, Ni YY et | Int J Biol Macromol | 2026 | 0 |
| Circadian disruption and its clinical implications in Parkinson's disease: A Nar [PMID:41905255] | Kataoka H, Saeki K, Sugie K, Obayashi K | Sleep medicine | 2026 | 0 |
| The neuroprotective role of eugenol against glyphosate-induced toxicity in rats: [PMID:41922126] | Bolat İ, Alat Ö, Orhan B, Dereli E, Teki | Tissue & cell | 2026 | 0 |
| Circadian abnormalities, molecular clock gene and chronobiological treatment for [PMID:41913359] | Chakraborty S, Srivastava V | Chronobiology international | 2026 | 0 |
| The rhythm of decline: Circadian disruption in neurodegeneration. [PMID:41066745] | Singh J, Kumar D, Kaur J, Singh A | Journal of food and drug analy | 2025 | 0 |
| Core Circadian Protein BMAL1: Implication for Nervous System Functioning and Its [PMID:41440117] | Smirnova KV, Smirnova LP, Amstislavskaya | Brain sciences | 2025 | 0 |
| Pharmacological targeting of BMAL1 modulates circadian and immune pathways. [PMID:40133642] | Pu H, Bailey LC, Bauer LG, Voronkov M, B | Nature chemical biology | 2025 | 0 |
| Circadian Rhythm Dysfunction in Neurodegenerative Diseases: A Bidirectional Pers [PMID:41287625] | Namgyal D, Lim CS | Nature and science of sleep | 2025 | 0 |
| Disrupted circadian control promotes oncogenesis in breast cancer. [PMID:41908013] | Fatima Y, Kashif M, Jain PA | Bioinformation | 2025 | 0 |
| Disruption of the circadian clock component BMAL1 elicits an endocrine adaption [PMID:35238641] | Jouffe C, Weger BD, Martin E, Atger F, W | Proceedings of the National Ac | 2022 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning REACTIVE ASTROCYTES in their description or question text
No additional research found